Literature DB >> 24435774

Comment on: FDG PET in the early diagnosis of large-vessel vasculitis.

Zdeněk Rehák1, Petr Szturz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24435774     DOI： 10.1007/s00259-013-2662-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  9 in total

1.  FDG-PET/CT of polymyalgia rheumatica.

Authors:  Takuya Kotani; Tsuyoshi Komori; Yumiko Kanzaki; Tohru Takeuchi; Daisuke Wakura; Akio Iimori; Suzue Hirano-Kuwata; Shigeki Makino; Toshiaki Hanafusa; Akira Ukimura
Journal:  Mod Rheumatol       Date:  2010-12-10       Impact factor: 3.023

2.  Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients.

Authors:  D Blockmans; L De Ceuninck; S Vanderschueren; D Knockaert; L Mortelmans; H Bobbaers
Journal:  Rheumatology (Oxford)       Date:  2006-11-18       Impact factor: 7.580

3.  F-18 FDG PET/CT of polymyalgia rheumatica.

Authors:  Akira Toriihara; Youhei Seto; Katsuya Yoshida; Isao Umehara; Tassei Nakagawa; Ren Liu; Itsuo Iwamoto
Journal:  Clin Nucl Med       Date:  2009-05       Impact factor: 7.794

4.  FDG PET in the early diagnosis of large-vessel vasculitis.

Authors:  P Sanchez-Roa; John Rees; J Nash; A Chander
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-24       Impact factor: 9.236

5.  Polymyalgia rheumatica and interspinous FDG uptake on PET/CT.

Authors:  Human Adams; Pieter Raijmakers; Yvo Smulders
Journal:  Clin Nucl Med       Date:  2012-05       Impact factor: 7.794

6.  Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis.

Authors:  Hiroyuki Yamashita; Kazuo Kubota; Yuko Takahashi; Ryogo Minamimoto; Miyako Morooka; Hiroshi Kaneko; Toshikazu Kano; Akio Mimori
Journal:  Joint Bone Spine       Date:  2012-06-29       Impact factor: 4.929

7.  Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.

Authors:  Hiroyuki Yamashita; Kazuo Kubota; Yuko Takahashi; Ryogo Minaminoto; Miyako Morooka; Kimiteru Ito; Toshikazu Kano; Hiroshi Kaneko; Hiroshi Takashima; Akio Mimoiri
Journal:  Mod Rheumatol       Date:  2011-12-29       Impact factor: 3.023

Review 8.  Clinical features of polymyalgia rheumatica and giant cell arteritis.

Authors:  Carlo Salvarani; Nicolò Pipitone; Annibale Versari; Gene G Hunder
Journal:  Nat Rev Rheumatol       Date:  2012-07-24       Impact factor: 20.543

Review 9.  Update on polymyalgia rheumatica.

Authors:  Nicolò Pipitone; Carlo Salvarani
Journal:  Eur J Intern Med       Date:  2013-04-08       Impact factor: 4.487
  9 in total
  2 in total

Review 1.  The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria?

Authors:  H Balink; R J Bennink; B L F van Eck-Smit; H J Verberne
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

Review 2.  FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.

Authors:  Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-11       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.